【レポートの概要(一部)】
TABLE OF CONTENTS
1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 YEARS CONSIDERED FOR THE STUDY 27
1.4 CURRENCY 27
1.5 STAKEHOLDERS 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
2.1.1 SECONDARY DATA 28
2.1.1.1 Key data from secondary sources 29
2.1.1 PRIMARY DATA 29
2.1.1.1 Breakdown of primaries 30
2.1.1.2 Key data from primary sources 30
2.1.1.3 Key industry insights 31
2.2 MARKET SIZE ESTIMATION 31
2.2.1.1 Bottom-up approach 32
2.2.1.2 Top-down approach 32
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 33
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 35
2.4.1 ASSUMPTIONS 35
2.4.2 LIMITATIONS 35
3 EXECUTIVE SUMMARY 36
3.1 INTRODUCTION 36
3.2 CURRENT SCENARIO 37
3.3 FUTURE OUTLOOK 38
3.4 CONCLUSION 40
4 PREMIUM INSIGHTS 41
4.1 ATTRACTIVE OPPORTUNITIES IN THE LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET 41
4.2 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET GROWTH RATE, BY TECHNOLOGY AND REGION (2014–2019) 42
4.3 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY AND REGION, 2014 ($MILLION) 43
4.4 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY, 2012–2019 ($MILLION) 44
5 MARKET OVERVIEW 45
5.1 INTRODUCTION 46
5.2 MARKET SEGMENTATION 46
5.2.1 BY TECHNOLOGY 47
5.2.2 BY END USER 47
5.3 MARKET DYNAMICS 48
5.3.1 DRIVERS 49
5.3.1.1 Increasing government spending on pharmaceutical R&D in emerging nations 49
5.3.1.2 Growing food safety concerns 50
5.3.1.3 Technological advancements in analytical devices 50
5.3.1.4 Funding sources increase the purchasing power of major research institutions 51
5.3.2 RESTRAINTS 52
5.3.2.1 High cost of instruments 52
5.3.2.2 Presence of alternative technologies 52
5.3.3 OPPORTUNITIES 53
5.3.3.1 Emerging markets offering lucrative growth opportunities 53
5.3.3.2 Growing proteomics market 53
5.3.3.3 Growing environmental safety concerns 54
5.3.3.4 Increasing demand from applied markets 55
5.3.3.5 Opportunity for lab automation solutions in biobank applications 55
5.3.4 CHALLENGES 56
5.3.4.1 Extensive requirements in developing chromatography systems that generate pressures of above 20,000 psi 56
5.3.4.2 Survival of small players in the lab automation market 56
5.3.4.3 Adoption and implementation of MIQE guidelines for publishing qPCR- and dPCR–based research 56
6 INDUSTRY INSIGHTS 57
6.1 INTRODUCTION 57
6.2 VALUE CHAIN ANALYSIS 57
6.3 INDUSTRY TRENDS 58
6.3.1 RISING FOCUS OF MARKET PLAYERS TOWARDS THE DEVELOPMENT OF MINIATURIZED INSTRUMENTS 58
6.3.2 INCREASING ADOPTION OF HYPHENATED TECHNOLOGIES 58
6.3.3 TIE-UPS BETWEEN ANALYTICAL INSTRUMENT MANUFACTURERS AND RESEARCH LABORATORIES/ACADEMIC INSTITUTIONS 59
6.4 PORTER’S FIVE FORCES ANALYSIS 59
6.4.1 THREAT OF NEW ENTRANTS 60
6.4.2 THREAT FROM SUBSTITUTES 61
6.4.3 BARGAINING POWER OF SUPPLIERS 61
6.4.4 BARGAINING POWER OF BUYERS 61
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 62
7 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY 63
7.1 INTRODUCTION 64
7.2 CHROMATOGRAPHY 65
7.2.1 DRIVERS 66
7.2.1.1 New international GMP & GDP certification for pharmaceutical excipients (North America & Europe): EXCiPACT 66
7.2.1.2 Industry support to research laboratories and academic institutes 67
7.2.1.3 Rise in government investments in chromatography technologies 67
7.2.1.4 Increased importance of chromatography tests in drug approvals 67
7.2.2 RESTRAINT 68
7.2.2.1 High cost of instruments 68
7.2.3 CHALLENGE 68
7.2.3.1 Obtaining identical results from UHPLC after transfer of HPLC to UHPLC 68
7.2.4 CHROMATOGRAPHY MARKET, BY TYPE 69
7.2.4.1 Liquid chromatography 69
7.2.4.2 Gas chromatography 70
7.2.4.3 Other chromatography techniques 71
7.2.5 MARKET SHARE ANALYSIS, BY KEY PLAYER 72
7.3 ELECTROPHORESIS 72
7.3.1 DRIVERS 74
7.3.1.1 Preferred technique for fragile molecules and variants 74
7.3.1.2 Increase in demand for 2D gel electrophoresis 74
7.3.1.3 Lab-on-a-Chip (LOC) technology 74
7.3.2 RESTRAINT 74
7.3.2.1 Alternative technologies provide better results 74
7.3.3 ELECTROPHORESIS MARKET, BY TYPE 75
7.3.3.1 Gel electrophoresis 75
7.3.3.2 Capillary electrophoresis 75
7.4 DNA SEQUENCERS & AMPLIFIERS 76
7.4.1 DRIVERS 77
7.4.1.1 Technological advancements 77
7.4.1.2 Increasing public and private investments, funds, and grants 78
7.4.1.3 Rising incidence of infectious diseases and genetic disorders 78
7.4.2 RESTRAINTS 79
7.4.2.1 High cost of equipment 79
7.4.3 DNA SEQUENCERS & AMPLIFIERS MARKET, BY TYPE 80
7.4.3.1 DNA sequencers 80
7.4.3.1.1 Market share analysis, by key player 81
7.4.3.2 DNA amplifiers 81
7.4.3.2.1 Thermal Cyclers 82
7.4.3.2.2 Real-time PCR 83
7.4.3.2.3 Others 83
7.5 LAB AUTOMATION 84
7.5.1 DRIVERS 86
7.5.1.1 Process miniaturization leading to low reagent cost and high productivity 86
7.5.1.2 Progress in drug discovery and clinical diagnostics 86
7.5.1.3 Large workforce demand and supply gap 87
7.5.1.4 Greater productivity and reduction in costs 87
7.5.1.5 Smaller volumes of samples and reagents required 87
7.5.2 RESTRAINTS 87
7.5.2.1 Automation not a priority for small- and medium-sized labs 87
7.5.2.2 Indefinite data interchange/communication standards 87
7.5.3 LAB AUTOMATION MARKET, BY TYPE 88
7.5.3.1 Automatic liquid handling 88
7.5.3.2 Microplate readers 88
7.5.3.3 Standalone robots 89
7.5.3.4 Automated storage and retrieval systems 90
7.5.3.5 Software and informatics 90
7.5.3.6 Others 92
7.5.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 93
7.6 SPECTROSCOPY 93
7.6.1 DRIVERS 95
7.6.1.1 Global alliances amongst leading research institutes to boost drug discovery 95
7.6.1.2 Atomic absorption spectroscopy to aid in the drug safety process 95
7.6.1.3 Increasing life science R&D spending 95
7.6.2 RESTRAINTS 96
7.6.2.1 High costs restrict purchase 96
7.6.2.2 Need for skilled professionals 96
7.6.3 SPECTROSCOPY MARKET, BY TYPE 96
7.6.3.1 Molecular spectroscopy 96
7.6.3.1.1 Market share analysis, by key player 97
7.6.3.2 Atomic spectroscopy 97
7.6.3.2.1 Market share analysis, by key player 98
7.6.3.3 Mass spectrometry 99
7.6.3.3.1 Market share analysis, by key player 99
7.7 IMMUNOASSAY 100
7.7.1 DRIVERS 102
7.7.1.1 Rising incidence of chronic and infectious diseases in emerging economies 102
7.7.1.2 Increasing number of approvals for immunoassay techniques 104
7.7.1.3 Advantages such as high sensitivity, low cost, and faster turnaround times 104
7.7.1.4 Increasing health awareness 105
7.7.2 RESTRAINTS 105
7.7.2.1 Low detection restricts adoption of immunoassay tests 105
7.7.2.2 Pricing pressure for some tests due to competition from lower cost-per-test technologies 105
7.7.3 IMMUNOASSAY MARKET, BY TYPE 105
7.7.3.1 Enzyme immunoassay (EIA) 105
7.7.3.2 Fluorescence immunoassay (FIA) 106
7.7.3.3 Chemiluminescence immunoassay (CLIA) 107
7.7.3.4 Radioimmunoassay (RIA) 107
7.7.3.5 Others 108
7.7.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 109
7.8 MICROARRAY 110
7.8.1 DRIVERS AND OPPORTUNITIES 111
7.8.1.1 Growth in personalized medicine 111
7.8.1.2 Technological advances 111
7.8.1.3 Increasing application areas 111
7.8.2 RESTRAINT 112
7.8.2.1 Lack of technical know-how 112
7.8.3 MICROARRAYS MARKET, BY TYPE 112
7.8.3.1 DNA microarrays 112
7.8.3.2 Protein microarrays 112
7.8.3.3 Tissue microarrays 113
7.8.3.4 Cell microarrays 113
7.9 FLOW CYTOMETRY 114
7.9.1 DRIVERS 116
7.9.1.1 Technological advancements in flow cytometry instruments 116
7.9.1.2 Fostering use of flow cytometry techniques in research activities 116
7.9.1.3 Increasing use of flow cytometry in clinical trials 117
7.9.1.4 Increasing use of flow cytometry in HIV and cancer research 117
7.9.1.5 Launch of new reagents for specific applications like diagnostics and drug discovery 117
7.9.2 RESTRAINTS 118
7.9.2.1 High cost of instruments 118
7.9.2.2 Reluctance among researchers in emerging countries to use flow cytometry 118
7.9.2.3 Lack of awareness and dearth of training 118
7.9.3 FLOW CYTOMETRY MARKET, BY TYPE 118
7.9.3.1 Cell-based flow cytometry 118
7.9.3.2 Bead-based flow cytometry 119
7.9.3.3 Others 120
7.9.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 121
7.10 OTHER INSTRUMENTS 121
7.10.1 CENTRIFUGES 122
7.10.2 LABORATORY BALANCES 123
7.10.2.1 Driver 123
7.10.2.1.1 Technological advancements in laboratory balances 123
7.10.2.2 Challenge 123
7.10.2.2.1 Effect of environmental disturbances 123
7.10.3 INCUBATORS 124
7.10.3.1 Drivers 124
7.10.3.1.1 Genetic engineering will drive the market 124
7.10.3.1.2 Stem cells and biological therapeutics increase the demand for CO2 incubators 124
7.10.3.2 Challenge 124
7.10.3.2.1 Contamination – A Major Concern 124
7.10.4 FUME HOODS 125
7.10.4.1 Driver 125
7.10.4.1.1 Improvements in device structure 125
7.10.4.2 Restraint 125
7.10.4.2.1 High electricity consumption 125
8 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY END USER 126
8.1 INTRODUCTION 127
8.2 CHROMATOGRAPHY 127
8.2.1 PHARMACEUTICAL COMPANIES AND CROS 129
8.2.2 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES 129
8.2.3 ACADEMIC RESEARCH LABORATORIES 130
8.2.4 AGRICULTURE & FOOD INDUSTRY 131
8.2.5 ENVIRONMENTAL TESTING 131
8.2.6 OTHERS 132
8.3 ELECTROPHORESIS 132
8.3.1 PHARMACEUTICAL COMPANIES AND CROS 133
8.3.2 BIOTECHNOLOGY COMPANIES AND LIFE SCIENCE RESEARCH INSTITUTIONS 133
8.3.3 FORENSIC SCIENCE AND CLINICAL DIAGNOSTIC LABORATORIES 134
8.3.4 ACADEMIC INSTITUTIONS 134
8.3.5 OTHERS 134
8.4 DNA SEQUENCERS & AMPLIFIERS 135
8.4.1 PHARMA & BIOTECH COMPANIES AND CROS 136
8.4.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 136
8.4.3 HOSPITALS AND DIAGNOSTIC CENTERS 137
8.4.4 FORENSIC SCIENCE LABORATORIES 137
8.5 LAB AUTOMATION 137
8.5.1 PHARMA & BIOTECH COMPANIES AND CROS 139
8.5.2 HOSPITALS AND PRIVATE LABS 139
8.5.3 RESEARCH INSTITUTIONS 140
8.5.4 ACADEMIC INSTITUTIONS 140
8.6 SPECTROSCOPY 140
8.6.1 PHARMACEUTICAL COMPANIES AND CROS 142
8.6.2 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES 142
8.6.3 ENVIRONMENTAL TESTING 143
8.6.4 FOOD AND BEVERAGE INDUSTRY 143
8.6.5 INDUSTRIAL CHEMISTRY 144
8.6.6 ACADEMIC INSTITUTIONS 144
8.6.7 OTHERS 145
8.7 IMMUNOASSAYS 145
8.7.1 HOSPITALS (PRIVATE/PUBLIC) 146
8.7.2 LABORATORIES (PRIVATE/PUBLIC) 146
8.7.3 PHARMACEUTICAL & BIOTECH COMPANIES AND CROS 147
8.7.4 ACADEMIC INSTITUTIONS 147
8.7.5 OTHERS 147
8.8 MICROARRAYS 148
8.8.1 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY 149
8.8.2 RESEARCH LABORATORIES 149
8.8.3 DIAGNOSTIC LABORATORIES 149
8.8.4 ACADEMIC INSTITUTIONS 150
8.8.5 OTHERS 150
8.9 FLOW CYTOMETRY 150
8.9.1 COMMERCIAL ORGANIZATIONS 151
8.9.2 ACADEMIC INSTITUTIONS 151
8.9.3 HOSPITALS 152
8.9.4 CLINICAL TESTING LABS 152
8.9.5 MEDICAL SCHOOLS 153
8.10 OTHER INSTRUMENTATION 154
8.10.1 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES AND CROS 154
8.10.2 RESEARCH LABORATORIES 154
8.10.3 ACADEMIC INSTITUTIONS 154
8.10.4 OTHERS 154
9 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET,
BY REGION 155
9.1 INTRODUCTION 156
9.2 NORTH AMERICA 158
9.2.1 FUNDING IN MEDICAL RESEARCH MAY DEVELOP NEW APPLICATION AREAS FOR ANALYTICAL TECHNOLOGIES 159
9.2.2 DRUG DEVELOPMENT REGULATIONS IN NORTH AMERICA 159
9.2.3 GROWING METABOLOMICS RESEARCH IN THE U.S. 160
9.2.4 CONFERENCES, DISCUSSIONS, SYMPOSIUMS, & SEMINARS 160
9.2.5 RISING PREVALENCE OF CHRONIC DISEASES AND AGING POPULATION 161
9.3 EUROPE 166
9.3.1 DIRECT AND INDIRECT FINANCIAL INVESTMENTS IN ANALYTICAL INSTRUMENTS 167
9.3.2 STRATEGIC ALLIANCES IN EUROPE TO TRIGGER THE GROWTH OF DRUG DISCOVERY 167
9.3.3 BURGEONING GROWTH OF THE EUROPEAN BIOSIMILARS MARKET 168
9.3.4 CONFERENCES AND SYMPOSIA 168
9.3.5 DEVELOPING PHARMACEUTICAL SECTOR IN RUSSIA 168
9.4 ASIA-PACIFIC 173
9.4.1 STRATEGIC EXPANSIONS BY KEY MARKET PLAYERS IN EMERGING ASIAN COUNTRIES 174
9.4.2 GROWING PHARMACEUTICAL INDUSTRY IN INDIA AND CHINA 174
9.4.3 EXTENSIVE CROP RESEARCH IN ASIA 175
9.4.4 GOVERNMENT INVESTMENTS IN THE BIOMEDICAL INDUSTRY IN CHINA 175
9.4.5 INFRASTRUCTURAL DEVELOPMENT IN VIETNAM 175
9.4.6 SINGAPORE, AN IMPORTANT MARKET FOR LIFE SCIENCE AND CHEMICAL INSTRUMENTATION 176
9.4.7 CONFERENCES, EXHIBITIONS, & MEETINGS ON ANALYTICAL INSTRUMENTS 176
9.5 REST OF THE WORLD 181
9.5.1 FLOURISHING BIOTECHNOLOGY & PHARMACEUTICAL MARKETS IN BRAZIL AND MEXICO 181
9.5.2 INCREASING R&D FUNDING IN THE LATIN AMERICAN REGION 181
9.5.3 HIGH PREVALENCE OF HIV IN AFRICAN REGION IS LIKELY TO OPEN NEW GROWTH POTENTIAL FOR THE LAB AUTOMATION, IMMUNOASSAY, AND PCR MARKETS 182
10 COMPETITIVE LANDSCAPE 187
10.1 INTRODUCTION 187
10.1.1 NEW PRODUCT LAUNCHES 189
10.1.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 190
10.1.3 EXPANSIONS 191
10.1.4 ACQUISITIONS 192
10.1.5 OTHER DEVELOPMENTS 193
11 COMPANY PROFILES 195
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 INTRODUCTION 195
11.2 AGILENT TECHNOLOGIES, INC. 196
11.3 BECTON, DICKINSON AND COMPANY 204
11.4 BIO-RAD LABORATORIES, INC. 208
11.5 BRUKER CORPORATION 213
11.6 DANAHER CORPORATION 218
11.7 F. HOFFMANN-LA ROCHE LTD. 224
11.8 PERKINELMER, INC. 228
11.9 SHIMADZU CORPORATION 233
11.10 THERMO FISHER SCIENTIFIC, INC. 239
11.11 WATERS CORPORATION 247
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
12 APPENDIX 253
12.1 INSIGHTS OF INDUSTRY EXPERTS 253
12.2 DISCUSSION GUIDE 254
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 256
12.4 AVAILABLE CUSTOMIZATIONS 256
12.5 RELATED REPORTS 257
【レポート販売概要】
■ タイトル:ライフサイエンス及び化学分析機器の世界市場:クロマトグラフィー装置、電気泳動、DNAシークエンサー、PCR、マイクロプレートリーダー等■ 英文:Life Science and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, Microplate Reader, Robotics, Spectroscopy, Immunoassay, Microarray, Flow Cytometer, Incubator, Fume Hood, Centrifuge) - Global Forecast to 2019
■ 発行日:2015年3月31日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-BT-3282
■ 調査対象地域:グローバル
- 粒子線治療の世界市場予測(~2023年)“The particle therapy market is projected to grow at a CAGR of 9.3% during the forecast period”The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%. The growth of this market is largely driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, i …
- デング熱(Dengue):疫学予測(~2023)EpiCast Report: Dengue - Epidemiology Forecast to 2023 Summary Dengue fever is a febrile illness caused by a single-stranded flavirius most commonly transmitted by the Aedes aegypti mosquito. Dengue fever is one of the most prevalent arthropod-borne diseases affecting humans. The severity of dengue fever ranges from asymptomatic cases, to classic dengue fever, and to DHF or DSS. GlobalData epidemi …
- グローライトの世界市場2019-2023Global Grow Light Market: About this market Technavio’s grow light market analysis considers sales from HID lights, LED lights, fluorescent lights, and others. Our analysis also considers the sales of grow light in APAC, Europe, North America, South America, and MEA. In 2018, the HID light segment had a significant market share. However, the LED light segment will have the largest market share dur …
- 放射線測定器・安全用品の世界市場:ガイガーカウンター、シンチレータ、半導体ベース検出器、放射線量計、放射線モニタ等The radiation detection, monitoring, and safety market is witnessing significant transformation with the changing landscape of nuclear power plants, homeland security and defense, and manufacturing industries. The growth of this market is majorly influenced by the dynamics of these industries. Global interest in the nuclear energy industry and its applications has led to an increase in the number …
- ポリフェニレンサルファイドの世界市場2017-2021About PPS PPS is available in a variety of grades that are appropriate for fluidized-bed coating, slurry coating, electrostatic spraying and injection, and compression molding. PPS is of two types, recycled PPS and virgin PPS. Recycled PPS has a lower price than virgin PPS. Recycled PPS has inferior properties and higher impurities than virgin PPS. Though recycled PPS offers advantages such as cos …
- 世界の手術用録画装置及びディスプレイ市場:カメラシステム、イメージキャプチャ及び録画装置、ディスプレイ及びPACSモニターThe Global Markets for Surgical Video Recording Devices and Surgical Displays report includes advanced systems that offer additional features such as: dual channel recording so two different imaging systems can be recorded at the same time, DICOM and PACS compatibility, and secure wireless system connectivity within hospitals. Many facilities have replaced their standard definition (SD) camera sys …
- 世界のNoSQL市場動向(2014-2018)TechNavio’s analysts forecast the Global NoSQL market will grow at a CAGR of 53.09 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased adoption of big data solutions. The Global NoSQL market has also been witnessing increasing demand for skilled professionals. However, the lack of awareness about the potential of NoSQL solutions could pose …
- 包装ロボットの世界市場2015-2019About packaging robots Packaging is a process of wrapping or covering a product to protect and preserve its inert quality from contamination or damage. It eases transportation, storage, and promotion of product to a large extent. Apart from providing convenience in handling products, it also includes essential information, such as price, contents, place of manufacturing or assembling, point of con …
- 世界のアルコール飲料(酒類)市場:ビール、ワイン、スピリッツ、ウイスキー、白酒(中国)、ウォッカ、ラム酒などAbout Alcoholic Drinks Alcoholic drinks comprise beer, spirits, and wine. In 2013, the Beer segment led the market with 53.24 percent and 75.34 percent share, respectively, in terms of revenue and volume. An increase in the demand among millennial population in the US, growing demand for premium alcoholic beverages, and increased marketing and promotions by vendors drive the consumption and sales …
- 医療用包装の世界市場2019-2023About this market Many pharmaceutical companies are investing heavily in R&D. Increased R&D spending by pharmaceutical manufacturers are expected to increase the number of pharmaceutical products in the market, thereby driving the demand for pharmaceutical packaging. By outsourcing packaging operation to third-party players. pharmaceutical manufacturers can reduce their capital expenditure and ope …
- 電子データキャプチャ(EDC)システムの世界市場分析:コンポーネント別、送達モード別(Webベース、ライセンス企業、クラウドベース)、開発フェーズ別(フェーズ1、2、3、4)、エンドユーザー別、セグメント予測、2014-2025The global electronic data capture (EDC) systems market is expected to reach USD 1.16 billion by 2025, according to a new study by Grand View Research, Inc. The rising demand for software solutions in clinical trials, increasing R&D expenditure by companies in healthcare, supportive government initiatives to boost trials, and increasing number of potential customers implementing Electronic Data Ca …
- LBS(位置情報サービス)の世界市場:追跡、ナビゲーション、インフォテイメント、分析、レクリエーションおよびフィットネスAbout location-based services LBS use location-enabled devices to track the location of users within the range of a wireless network. This is done with the help of GIS and the Internet. Location-enabled mobile devices such as smartphones, tablets, PNDs; and location-enabled in-dash devices can search for places and routes; obtain traffic updates and real-time directions; provide information on cur …
- 堅牢型機器の世界市場2017-2021:堅牢型通信装置、堅牢型パソコン、堅牢型ディスプレイAbout Rugged EquipmentMilitary-based rugged equipment follows specific military standards (MIL-STD), while industrial rugged equipment follows ingress protection (IP) grades. IP Code is the international standard used to classify protection against solid objects and water. The IP rating consists of two numbers. The higher the numbers, the more durable the product. The demand for rugged equipment i …
- 弾性接着剤およびシーラントの世界市場:ポリウレタン接着剤、シリコーン接着剤、シラン変性樹脂The report covers the global elastic bonding adhesive & sealant market. It divides the market on the basis of types, applications and regions. The market data for these types is given with respect to volume (Kilo Tons) and value ($Million). The market size in terms of volume of elastic bonding adhesive & sealant is projected to reach $20 billion by 2020 with a CAGR of 6.1% between 2015 and 2020. T …
- 2014年戦略提言:日本の血液凝固検査市場Complete report $7,400. DataPack (test volumes, sales forecasts, supplier shares) $4,800.SummaryThis comprehensive report contains 402 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Japanese coagulation testing market during the next five years. The report explores business and techn …